Literature DB >> 8262638

2-Deoxy-D-glucose inhibits intracellular multiplication and promotes intracellular killing of Legionella pneumophila in A/J mouse macrophages.

M Ogawa1, S Yoshida, Y Mizuguchi.   

Abstract

Legionella pneumophila can grow intracellularly in A/J mouse macrophages. 2-Deoxy-D-glucose (2dG) (0.1, 1, and 10 mM) inhibited intracellular multiplication and promoted intracellular killing of L. pneumophila dose dependently when it was added to the culture medium of macrophage monolayers, whereas it did not inhibit the bacterial growth in buffered yeast extract broth, which was used for an L. pneumophila culture. The effect of 2dG was reversible because the surviving bacteria resumed intracellular multiplication after the washing away of 2dG from the culture. The effect of 2dG was also competitively inhibited by high concentrations of glucose. The inhibitory effect of 2dG was not attributed to the inhibition of bacterial phagocytosis by macrophages. Furthermore, sodium fluoride (0.1 and 1 mM), cycloheximide (0.1 and 1 microgram/ml), and tunicamycin (1, 2, and 5 micrograms/ml) did not promote the killing of L. pneumophila in macrophages, implying that the inhibitory effect of 2dG cannot be attributed to the inhibition of glycolysis, protein synthesis, and protein glycosylation in macrophages. We suggest that 2dG promotes intracellular killing of L. pneumophila by activating some novel killing mechanism of macrophages.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8262638      PMCID: PMC186096          DOI: 10.1128/iai.62.1.266-270.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

2.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

3.  Liquid medium for growth of Legionella pneumophila.

Authors:  J D Ristroph; K W Hedlund; R G Allen
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

4.  Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil.

Authors:  M A Horwitz
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

5.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

6.  Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.

Authors:  T W Nash; D M Libby; M A Horwitz
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

7.  2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages II. Dissociation of the inhibitory effects of 2-deoxyglucose on phagocytosis and ATP generation.

Authors:  J Michl; D J Ohlbaum; S C Silverstein
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

8.  2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages. I. Description of the inhibitory effect.

Authors:  J Michl; D J Ohlbaum; S C Silverstein
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

9.  The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.

Authors:  M A Horwitz
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

10.  Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes.

Authors:  M A Horwitz
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  6 in total

1.  Glucose metabolism in Legionella pneumophila: dependence on the Entner-Doudoroff pathway and connection with intracellular bacterial growth.

Authors:  Eiji Harada; Ken-Ichiro Iida; Susumu Shiota; Hiroaki Nakayama; Shin-Ichi Yoshida
Journal:  J Bacteriol       Date:  2010-04-02       Impact factor: 3.490

2.  Glycolytic inhibitor 2-deoxyglucose suppresses inflammatory response in innate immune cells and experimental staphylococcal endophthalmitis.

Authors:  Rebecca Francis; Pawan Kumar Singh; Sukhvinder Singh; Shailendra Giri; Ashok Kumar
Journal:  Exp Eye Res       Date:  2020-05-23       Impact factor: 3.467

3.  Legionella pneumophila Is Directly Sensitive to 2-Deoxyglucose-Phosphate via Its UhpC Transporter but Is Indifferent to Shifts in Host Cell Glycolytic Metabolism.

Authors:  Jordan V Price; Kallie Jiang; Abigail Galantowicz; Alana Freifeld; Russell E Vance
Journal:  J Bacteriol       Date:  2018-07-25       Impact factor: 3.490

4.  Comparative Genomics Reveal That Host-Innate Immune Responses Influence the Clinical Prevalence of Legionella pneumophila Serogroups.

Authors:  Mohammad Adil Khan; Natalie Knox; Akriti Prashar; David Alexander; Mena Abdel-Nour; Carla Duncan; Patrick Tang; Hajera Amatullah; Claudia C Dos Santos; Nathalie Tijet; Donald E Low; Christine Pourcel; Gary Van Domselaar; Mauricio Terebiznik; Alexander W Ensminger; Cyril Guyard
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 5.  On the offense and defense: mitochondrial recovery programs amidst targeted pathogenic assault.

Authors:  Siraje A Mahmud; Mohammed A Qureshi; Mark W Pellegrino
Journal:  FEBS J       Date:  2021-07-16       Impact factor: 5.622

6.  Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axis.

Authors:  Johannes J Kovarik; Elisabeth Kernbauer; Markus A Hölzl; Johannes Hofer; Guido A Gualdoni; Klaus G Schmetterer; Fitore Miftari; Yury Sobanov; Anastasia Meshcheryakova; Diana Mechtcheriakova; Nadine Witzeneder; Georg Greiner; Anna Ohradanova-Repic; Petra Waidhofer-Söllner; Marcus D Säemann; Thomas Decker; Gerhard J Zlabinger
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.